Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis (Q33218589)

24 July 2017

Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis (English)

1 reference

24 July 2017

1 reference

Anastasios Tahmatzopoulos

series ordinal

1

1 reference

24 July 2017

Shijie Sheng

series ordinal

2

1 reference

24 July 2017

Natasha Kyprianou

series ordinal

3

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

24 July 2017

1 reference

24 July 2017

24

1 reference

24 July 2017

34

1 reference

24 July 2017

5375-5383

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208684

24 July 2017

0 references

cites work

Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

21 June 2018

Cancer statistics, 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Role of Maspin in Tumor Metastasis and Angiogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

What's new in the treatment of advanced prostate cancer?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Maspin sensitizes breast carcinoma cells to induced apoptosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Endocrine therapy of prostate cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208684

Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208684

Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208684

Bax mediates the apoptosis-sensitizing effect of maspin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208684

Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Production, purification, and characterization of recombinant maspin proteins.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2274915

Transforming growth factor beta 1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16007219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Maspin is an angiogenesis inhibitor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16007219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Epigenetic silencing of maspin gene expression in human breast cancers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16007219

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208684

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference